Both in Biotechnology
Aligos Therapeutics vs Cel-Sci
Over the past year ALGS returned −44.5% and CVM returned −81.4%; their daily moves had a correlation of 0.06.
ALGS −44.5% CVM −81.4%Growth of $1, one year, split-adjusted
| Metric | ALGS | CVM |
|---|---|---|
| Price | $5.17 | $1.60 |
| Market cap | $32.3M | $28.1M |
| Today | +9.07% | +1.91% |
| 1 month | −8.0% | −10.6% |
| 6 months | −13.4% | −45.0% |
| Year to date | −44.5% | −69.6% |
| 1 year | −47.1% | −82.3% |
| Revenue growth (YoY) | +2778.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −5.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | $30.3M | $255.6K |
| Dividend yield | — | — |
| Volatility (60d) | 96.1% | 100.0% |
| Short % of float | 12.7% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).